Pregabalin Can Cause Constipation
Yes, pregabalin does cause constipation as a recognized adverse effect, though it occurs less frequently than other common side effects like dizziness and somnolence.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for pregabalin explicitly lists constipation as an adverse reaction across multiple indications 1. In controlled trials:
- Partial-onset seizures (adults): Constipation occurred in 4% of pregabalin patients vs. 2% on placebo, with dose-related incidence of 1% (150 mg/day), 1% (300 mg/day), and 7% (600 mg/day) 1
- Neuropathic pain associated with spinal cord injury: Constipation occurred in 8.2% of pregabalin patients vs. 5.7% on placebo 1
Importantly, the FDA label includes postmarketing reports of serious gastrointestinal complications: "events related to reduced lower gastrointestinal tract function (e.g., intestinal obstruction, paralytic ileus, constipation) when pregabalin was co-administered with medications that have the potential to produce constipation, such as opioid analgesics" 1.
Clinical Context from Guidelines
Multiple clinical practice guidelines acknowledge constipation as a pregabalin side effect:
- The 2017 neuropathic corneal pain guideline lists "constipation" among common side effects of gabapentinoids (gabapentin and pregabalin) 2
- The 2022 gastroparesis management guideline notes that pregabalin can cause "constipation" as a side effect when used for neuropathic pain 3
- The 2011 painful diabetic neuropathy consensus identifies "constipation" among the most frequent side effects of pregabalin 4
Research Evidence
A comprehensive 2015 pooled analysis of 31 randomized trials (7,510 patients, 805 patient-years of pregabalin exposure) identified constipation with a risk difference of 2.3% (95% CI: 1.5-3.2%) compared to placebo 5. This analysis established constipation as one of nine adverse events with clinically meaningful increased risk.
Recent case reports further document this effect:
- A 2023 case report described a 76-year-old woman who developed constipation (along with balance disorder, asthenia, and edema) on pregabalin 300 mg daily, with symptoms improving upon dose reduction 6
- A 2026 post-bunionectomy pain trial noted "mild constipation" as more common in pregabalin groups 7
Clinical Implications
Constipation from pregabalin is:
- Dose-related: Higher doses (600 mg/day) show 7% incidence vs. 1% at lower doses 1
- Less common than neurological side effects: Dizziness (17% risk difference) and somnolence (10.8% risk difference) are far more frequent 5
- Potentially serious when combined with opioids: The FDA specifically warns about reduced GI motility complications when pregabalin is co-prescribed with constipating medications 1
Management approach:
- Anticipate constipation prophylactically in patients on higher pregabalin doses (≥600 mg/day)
- Exercise particular caution when combining pregabalin with opioids or other constipating medications
- Consider dose reduction if constipation becomes problematic, as demonstrated in the case report where reducing from 300 mg to 150 mg daily resolved symptoms 6
- Monitor elderly patients more closely, as they may be more susceptible to dose-related adverse effects 6